Prism Medico and Pharmacy share news, announcements and annual reports
Share price at the BSE close on 30 Oct 2026. Previous close ₹35.80.
30 Oct: open ₹34.52, high ₹36.60, low ₹34.00
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹48 Cr4,315th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- Shares changed
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- −2.6%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −2.5%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.00
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 42,981
Prism Medico and Pharmacy share news and announcements
818 announcements, routine notices left out, newest first. Page 5 of 17.
Apr 2023
28 Apr · Submission Of Certificate Under Regulation 40(9) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Financial Year Ended 31St March 2023.
28 Apr · Submission Of Compliance Certificate Certifying The Maintenance Of Physical And Electronic Share Transfer Facility As Per Regulation 7(3) Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 During The Financial Year Ended 31St March, 2023.
20 Apr · Investor Complaints As Per Regulation 13(3) Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015.
20 Apr · Non-Applicability Of Regulation 27 On Corporate Governance Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Quarter Ended 31St March, 2023.
7 Apr · Compliance-57 (5) : intimation after the end of quarter
Mar 2023
14 Mar · Post Offer Advertisement
Feb 2023
20 Feb · Offer Opening Public Announcement
17 Feb · Updates on Open Offer
16 Feb · Outcome Of Meeting Of Committee Of Independent Directors For Open Offer Of Prism Medico And Pharmacy Limited.
9 Feb · Corrigendum to Detailed Public Statement
3 Feb · Board meeting
Meeting on 13 Feb 2023: quarterly results
Jan 2023
23 Jan · Non-Applicability Of Regulation 27 On Corporate Governance Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Quarter Ended 31St December, 2022.
16 Jan · Investor Complaints As Per Regulation 13(3) Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015.
Dec 2022
12 Dec · Draft Letter of Offer
5 Dec · Detailed Public Statement
Nov 2022
14 Nov · Board meeting
4 Nov · Board meeting
Meeting on 14 Nov 2022: quarterly results
Oct 2022
20 Oct · Investor Complaints As Per Regulation 13(3) Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015.
20 Oct · Statement Of Investor Complaints For The Quarter Ended September 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 03 Oct · Meeting
Sep 2022
1 Sep · Board meeting
Meeting on 5 Sep 2022: annual general meeting
Aug 2022
13 Aug · Board meeting
8 Aug · Board meeting
Meeting on 13 Aug 2022: quarterly results
Jul 2022
20 Jul · Statement Of Investor Complaints For The Quarter Ended June 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
May 2022
25 May · Board meeting
17 May · Board meeting
Meeting on 25 May 2022: audited results
Apr 2022
26 Apr · Intimation Under Regulation 32 Of SEBI (Listing Obligations & Disclosure Requirement) Regulations, 2015